Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

Coronary Artery Disease V: Interprofessional Care

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

Cardiomyopathy VI: Nursing Management

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...

Cardiomyopathy II: Dilated Cardiomyopathy

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

Introduction Cardiac Emergencies

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Ligand-complex-based quantification of β2-integrin-mediated affinity and avidity of murine T cells.

Animal models and experimental medicine·2026

Same author

Letter to the Editor: 250th cardiac arrest center certification in Germany.

Clinical research in cardiology : official journal of the German Cardiac Society·2025

Same author

Comparative analysis of cryoballoon versus radiofrequency catheter ablation in atrial fibrillation patients with impaired left ventricular ejection fraction.

International journal of cardiology. Heart & vasculature·2025

Same author

The cardio-oncologic burden of breast cancer: molecular mechanisms and importance of preclinical models.

Basic research in cardiology·2024

Same author

Macrophages enhance sodium channel expression in cardiomyocytes.

Basic research in cardiology·2024

Same author

Cardiomyocyte-specific RXFP1 overexpression protects against pressure overload-induced cardiac dysfunction independently of relaxin.

Biochemical pharmacology·2024

Search research articles

Related Experiment Video

Updated: Mar 2, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

[Choosing wisely recommendations in cardiology].

K Werdan^1,2, S Baldus^3,4, N Frey^3,5

¹Deutsche Gesellschaft für Kardiologie - Herz- und Kreislaufforschung, Grafenberger Allee 100, 40237, Düsseldorf, Deutschland. karl.werdan@medizin.uni-halle.de.

|May 13, 2017

Summary

German Cardiac Society guidelines suggest anticoagulation for moderate stroke risk atrial fibrillation patients and goal-directed LDL cholesterol lowering for coronary heart disease. These recommendations aim to optimize patient outcomes and treatment strategies.

Keywords:

Anticoagulants Atrial fibrillation Cholesterol, LDL Coronary disease Hydroxymethylglutaryl-CoA reductase inhibitors

More Related Videos

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

Related Experiment Videos

Last Updated: Mar 2, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

Area of Science:

Cardiology
Preventive Medicine

Background:

Controversial Choosing Wisely recommendations from the German Cardiac Society are discussed.
These include anticoagulation for moderate stroke risk atrial fibrillation and goal-directed LDL cholesterol lowering.

Purpose of the Study:

To analyze the German Cardiac Society's recommendations on anticoagulation for atrial fibrillation and LDL cholesterol management.
To discuss the rationale behind prioritizing goal-oriented statin therapy over fixed-dose strategies.

Main Methods:

Review of German Cardiac Society guidelines.
Analysis of recommendations for atrial fibrillation and coronary heart disease patient management.

Main Results:

Anticoagulation therapy benefits patients with atrial fibrillation and moderate stroke risk (CHA2DS2-VASc Score 1 in men, 2 in women), including the elderly.
For coronary heart disease, a target LDL cholesterol below 70 mg/dl (1.8 mmol/l) or at least a 50% reduction from baseline is recommended.

Conclusions:

The German Cardiac Society emphasizes goal-oriented statin therapy for LDL cholesterol reduction.
These guidelines aim to refine treatment strategies for atrial fibrillation and coronary heart disease.